Analyst Ratings for CME Group Inc. Cl A (CME)

Updated: 2017-07-28

CME Group Inc. Cl A (NASDAQ:CME) was awarded an average rating of Overweight from investment analysts following the stock. CME had previously received a consensus rating of Overweight a month ago.

16 analysts issued ratings on the stock, where 9 gave CME a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

CME was given price targets by several analysts. The most optimistic analyst gave a price target of 140, implying potential capital gains of 15.3 percent. The most pessimistic analyst gave a price target of 106, which equates to a potential downside of -12.7 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates downwards for this quarter, by about -1.23 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -3.23 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -0.51 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 2 analysts increased their quarterly estimates, which can be compared to the 5 analysts that decreased their estimates. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 4 analysts that revised their FY estimates downwards.

CME has an estimated earnings growth rate of 4.99 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of CME is 5.27.

CME has a 52-week high of 127.96 and a 52-week low of 98.95. Today's price is 22.71 percent above the 52-week low, and 5.11 percent lower than its 52-week high. CME has a price/earnings ratio of 26.3. Investors typically compare the P/E ratio to a company's peers in the industry. The CME value stock report compares CME to some of its peers using value stock charts. The market cap of CME is $41.24 billion. CME will post this quarters earnings in days, on 0000-00-00.